HIK Hikma Pharmaceuticals Plc

RNS Number:6863T
Hikma Pharmaceuticals Plc
04 November 2005


NOTIFICATION OF TRANSACTIONS OF DIRECTORS, 
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS


This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).

(1)     An issuer making a notification in respect of a transaction 
        relating to the shares or debentures of the issuer should complete
        boxes 1 to 16, 23 and 24.
(2)     An issuer making a notification in respect of a derivative relating 
        to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 
        16, 23 and 24. 
(3)     An issuer making a notification in respect of options granted to a 
        director/person discharging managerial responsibilities should 
        complete boxes 1 to 3 and 17 to 24. 
(4)     An issuer making a notification in respect of a financial 
        instrument relating to the shares of the issuer (other than a 
        debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 
        23 and 24. 


Please complete all relevant boxes in block capital letters.


1.  Name of the issuer   
           
    HIKMA PHARMACEUTICALS PLC


2.  State whether the notification relates to (i) a transaction 
    notified in accordance with DR 3.1.4R(1)(a); or

    (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 
    (as extended by section 328) of the Companies Act 1985; or 

    (iii) both (i) and (ii)

    (iii)

               
3.  Name of person discharging managerial responsibilities/director  

    SIR DAVID ROWE-HAM (DIRECTOR)

        
4.  State whether notification relates to a person connected with a person
    discharging managerial responsibilities/director named in 3 and identify the 
    connected person
 
    N/A

        
5.  Indicate whether the notification is in respect of a holding of the person 
    referred to in 3 or 4 above or in respect of a non-beneficial interest      

    3 ABOVE


6.  Description of shares (including class), debentures or derivatives or 
    financial instruments relating to shares

    ORDINARY SHARES OF 10 PENCE EACH

               
7.  Name of registered shareholders(s) and, if more than one, the number of
    shares held by each of them   

    SIR DAVID ROWE-HAM


8.  State the nature of the transaction
               
    ACQUISITION OF SHARES


9.  Number of shares, debentures or financial instruments relating to shares 
    acquired 

    10,000


10. Percentage of issued class acquired (treasury shares of that class should 
    not be taken into account when calculating percentage)

    0.006%

               
11. Number of shares, debentures or financial instruments relating to shares
    disposed     

    N/A


12. Percentage of issued class disposed (treasury shares of that class should
    not be taken into account when calculating percentage) 

    N/A

               
13. Price per share or value of transaction    

    281 PENCE PER SHARE


14. Date and place of transaction

    4 NOVEMBER 2005, LONDON
               

15. Total holding following notification and total percentage holding following 
    notification (any treasury shares should not be taken into account when 
    calculating percentage)   

    10,000 ORDINARY SHARES (0.006%)


16. Date issuer informed of transaction

    4 NOVEMBER 2005
               

If a person discharging managerial responsibilities has been granted options by 
the issuer complete the following boxes




17. Date of grant   




18. Period during which or date on which it can be exercised



               
19. Total amount paid (if any) for grant of the option  




20. Description of shares or debentures involved (class and number)



               
21. Exercise price (if fixed at time of grant) or indication that price is 
    to be fixed at the time of exercise     




22. Total number of shares or debentures over which options held following 
    notification
               



23. Any additional information  

    N/A


24. Name of contact and telephone number for queries

    HENRY KNOWLES, COMPANY SECRETARY, 0207 859 2817

               

Name and signature of duly authorised officer of issuer responsible for 
making notification

HENRY KNOWLES, COMPANY SECRETARY, 0207 859 2817


Date of notification 

4 NOVEMBER 2005




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

RDSBUBDBIBGGGUS

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024